🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
05/09/2007 0,3626 USD
06/06/2007 0,3626 USD
07/03/2007 0,3626 USD
06/12/2006 0,3626 USD
30/08/2006 0,3626 USD
31/05/2006 0,3626 USD
08/03/2006 0,3626 USD
30/11/2005 0,3626 USD
31/08/2005 0,3626 USD
01/06/2005 0,3626 USD
02/03/2005 0,3626 USD
01/12/2004 0,3626 USD
01/09/2004 0,3626 USD
02/06/2004 0,3531 USD
03/03/2004 0,3531 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/07/1989 10,83 10,95 10,77 10,91 +0,92% 1,65% 3.782.861
05/07/1989 10,75 10,85 10,62 10,81 +0,37% 2,22% 5.577.456
03/07/1989 10,64 10,79 10,60 10,77 +1,31% 1,87% 1.997.069
30/06/1989 10,79 10,79 10,56 10,64 -1,47% 2,21% 6.833.170
29/06/1989 10,93 10,95 10,77 10,79 -2,16% 1,64% 4.128.072
28/06/1989 11,09 11,09 10,85 11,03 -0,72% 2,15% 4.021.805
27/06/1989 10,99 11,17 10,99 11,11 +0,90% 1,63% 4.709.083
26/06/1989 11,13 11,13 10,81 11,01 -0,89% 2,86% 3.498.014
23/06/1989 10,93 11,13 10,81 11,11 +3,33% 2,91% 5.859.158
22/06/1989 10,71 10,79 10,68 10,75 +0,93% 1,11% 3.588.562
21/06/1989 10,73 10,77 10,62 10,66 -0,56% 1,48% 4.030.608
20/06/1989 10,81 10,87 10,50 10,71 -0,92% 3,49% 3.197.448
19/06/1989 10,87 10,91 10,81 10,81 -1,09% 0,91% 3.482.923
16/06/1989 10,75 11,01 10,75 10,93 +1,10% 2,40% 9.140.237
15/06/1989 10,81 10,91 10,75 10,81 -0,37% 1,47% 6.296.174
14/06/1989 10,95 10,95 10,77 10,85 -0,73% 1,63% 7.583.328
13/06/1989 11,05 11,07 10,89 10,93 -3,00% 1,62% 8.727.115
12/06/1989 11,31 11,41 11,17 11,27 -0,53% 2,11% 3.573.470
09/06/1989 11,29 11,35 11,21 11,33 +0,00% 1,23% 4.178.376
08/06/1989 11,43 11,43 11,31 11,33 -0,87% 1,04% 3.399.293
07/06/1989 11,39 11,49 11,35 11,43 +0,35% 1,22% 3.977.160
06/06/1989 11,29 11,39 11,23 11,39 +1,06% 1,41% 4.296.590
05/06/1989 11,43 11,43 11,23 11,27 -1,56% 1,74% 4.026.835
02/06/1989 11,19 11,45 11,17 11,45 +3,04% 2,49% 5.686.238
01/06/1989 11,01 11,17 11,01 11,11 +0,72% 1,44% 3.538.258
31/05/1989 10,89 11,09 10,89 11,03 +0,91% 1,82% 4.657.522
30/05/1989 11,15 11,19 10,93 10,93 -2,48% 2,32% 4.868.798
26/05/1989 11,11 11,27 11,11 11,21 +0,89% 1,43% 3.617.486
25/05/1989 10,99 11,13 10,95 11,11 +1,45% 1,63% 5.805.082
24/05/1989 10,93 11,03 10,77 10,95 -1,61% 2,36% 11.217.163